Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
With medical research and technology shaping this condition that results in kidney enlargement due to urine retention, the Hydronephrosis Market is advancing remarkably. An example of a market trend is growing prevalence of minimally invasive hydronephrosis surgical procedures. Ureteroscopy and percutaneous nephrostomy, endoscopic steps, have become more popular since they are less invasive, faster and with fewer complications. These trends give priority to treatments that are patient-friendly and effective.
The Hydronephrosis Market has also embraced other diagnostic modalities especially imaging. For instance, Ultrasound, CT scanning or MRI are used for diagnosing hydronephrosis. This change emphasizes the need for early accurate detection to develop treatment plans that will work best for this disease.
Pharmaceutical treatment options for hydronephrosis have improved as well. Urinary flow enhancement and reduction of renal oedema are some of the avenues being pursued by researchers and drug firms on pee obstruction and reflux treatments. Such progress may culminate in non-invasive ways of treating hydronephrosis.
Robotic-assisted surgery is gaining popularity within the Hydronephrosis Market too. Robot-assisted pyeloplasty is less invasive than primary open surgery because it offers precision as well as control during operation. Robotic technologies can improve surgical results and contribute to better patients’ experience.
Market interest is also rising around pediatric hydronephroses cases. Prenatal/neonatal imaging has improved identification of hydronephroses among newborns hence allowing early intervention. It indicates that paediatric care should focus on individual cases associated with hydronephroses children.
Patient education initiatives are also part of what shapes the Hydrocephalus market across various countries around the world. Educating people about symptoms, risk factors and treatment alternatives enhance early diagnosis and therapy outcomes. It further highlights the importance of proactive healthcare seeking and enlightened patient choices.
The Hydronephrosis Market also involves medical research institutes, pharmaceutical corporations, and health care organizations. They work together to come up with innovative ideas on how to provide patients with better alternatives for treatment. This can be achieved by working together in order to understand hydronephroses more fully and thereafter progress in research.
Preventive and conservative management is growing in significance within the Hydrocephalus Market as well. Hydration and weight management can be advised to avoid urinary tract obstructions as well as hydronephroses. Proactive approach to health care seeks to enable people incorporate lifestyle practices that help them avoid specific types of hydronephroses.”
Hydronephrosis Market Highlights:
Hydronephrosis Market Overview
Hydronephrosis Market Size was valued at USD 3.22 Billion in 2023. The Global Hydronephrosis industry is projected to grow from USD 3.57 Billion in 2024 to USD 8.16 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 11.20% during the forecast period (2024 - 2032).
Hydronephrosis is a condition characterized by a swollen kidney as a result of abnormal drainage of urine from the kidney to the bladder. It is a secondary disease that results from primary disease that may affect the kidney. Symptoms of hydronephrosis includes fever, pain when urinating, nausea or vomiting, and pain in the abdomen. It may be unilateral or bilateral. Unilateral hydronephrosis is swelling of one kidney, whereas, bilateral hydronephrosis is swelling of both the kidneys. Hydronephrosis is mostly diagnosed through ultrasound examination.
Hydronephrosis has become a major problem across the globe due to rising prevalence of kidney diseases, lack of awareness about the diseases and their treatment, which favor the growth of the market. Rising prevalence of kidney diseases especially, in the geriatric population and availability of cost-effective treatment propel the market growth.
Hydronephrosis Market Segment Insights
The hydronephrosis market is segmented on the basis of types, which includes unilateral hydronephrosis and bilateral hydronephrosis.
Hydronephrosis Diagnosis Insights
On the basis of diagnosis, the hydronephrosis market is segmented into laboratory test and imaging. Laboratory test is further segmented into urinalysis, Complete Blood Count (CBC), electrolyte analysis, and others. Imaging is further sub-segmented into CT scan, ultrasound, intravenous pyelography, KUB X-rays, and others.
Hydronephrosis Treatment Insights
On the basis of treatment, the hydronephrosis market is segmented into shock wave lithotripsy, laparoscopy, bladder catheterization, steroid therapy, and others.
Hydronephrosis Indication Insights
On the basis of indication the hydronephrosis market is segmented into intrinsic and extrinsic causes of hydronephrosis. The intrinsic causes are further sub-segmented into acute unilateral obstructive uropathy, kidney stone, bladder cancer, bladder stones, cystocele, urethral stricture, urethral cancer and others. The extrinsic causes are further sub-segmented into retroperitoneal fibrosis, ovarian vein syndrome, cancer of the cervix, cancer of the prostate, uterine prolapse, prostate cancer, and others.
Hydronephrosis Regional Insights
The American region accounted for the largest share of the global market due to increasing prevalence of chronic kidney diseases, and rising demand for diagnosis and treatment of hydronephrosis. Hydronephrosis are leading urological diseases in the U.S. According to the Center for Diseases Control and Prevention, 48,146 deaths occurred due to nephrosis and kidney diseases in the year 2014. It also stated that the number of adults diagnosed with kidney diseases in 2014 was 4.9 million in the US.
Europe is the second largest market that holds a noticeable share of the hydronephrosis market. According to the European database for surveillance of congenital malformations report, hydronephrosis is prevalence among new born and pregnant women.
In Asia Pacific, rising prevalence of kidney stone, rising geriatric population and growing demand for counselling about hydronephrosis drive the market growth.
The Middle East & Africa is expected to show a steady growth in this market due constant demand for diagnostics devices, awareness about maternal and child health in most of the African countries and the government efforts to cater primary health need of the population.The report on the hydronephrosis market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The hydronephrosis market report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions.
Key Players in the Hydronephrosis Market
Some of the key players in hydronephrosis market are
- NephroGenex, Inc. (U.S)
- American Renal Associates (U.S)
- PHRAXIS, INC. (U.S)
- Renal Associates P.A. (U.S)
- ALLERGAN (U.S)
- Amgen Inc. (U.S)
- Anthem Bio Pharm (U.S)
- Sanofi (U.S)
- Novartis AG (Germany)
Intended Audience
- Medical Device Manufacturers
- Medical Device Suppliers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
